104 related articles for article (PubMed ID: 25392796)
21. Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer.
Anderson WF; Chen BE; Jatoi I; Rosenberg PS
Breast Cancer Res Treat; 2006 Nov; 100(1):121-6. PubMed ID: 16685588
[TBL] [Abstract][Full Text] [Related]
22. Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis.
Abrams MJ; Koffer PP; Wazer DE; Hepel JT
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):384-391. PubMed ID: 28463158
[TBL] [Abstract][Full Text] [Related]
23. A prediction model for the presence of axillary lymph node involvement in women with invasive breast cancer: a focus on older women.
Greer LT; Rosman M; Charles Mylander W; Liang W; Buras RR; Chagpar AB; Edwards MJ; Tafra L
Breast J; 2014; 20(2):147-53. PubMed ID: 24475876
[TBL] [Abstract][Full Text] [Related]
24. Squamous cell carcinoma of the breast in the United States: incidence, demographics, tumor characteristics, and survival.
Yadav S; Yadav D; Zakalik D
Breast Cancer Res Treat; 2017 Jul; 164(1):201-208. PubMed ID: 28432512
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
26. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
Jacobs AJ; Morris CD; Levin AS
Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
[TBL] [Abstract][Full Text] [Related]
27. Predictors of Surgery Types after Neoadjuvant Therapy for Advanced Stage Breast Cancer: Analysis from Florida Population-Based Cancer Registry (1996-2009).
Al-Azhri J; Koru-Sengul T; Miao F; Saclarides C; Byrne MM; Avisar E
Breast Cancer (Auckl); 2015; 9():99-108. PubMed ID: 26691964
[TBL] [Abstract][Full Text] [Related]
28. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.
Anderson WF; Jatoi I; Devesa SS
Breast Cancer Res Treat; 2005 Mar; 90(2):127-37. PubMed ID: 15803359
[TBL] [Abstract][Full Text] [Related]
29. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
30. Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis.
Liu N; Johnson KJ; Ma CX
Clin Breast Cancer; 2018 Oct; 18(5):e997-e1002. PubMed ID: 30007834
[TBL] [Abstract][Full Text] [Related]
31. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
[TBL] [Abstract][Full Text] [Related]
32. Socioeconomic disparities and breast cancer hormone receptor status.
Andaya AA; Enewold L; Horner MJ; Jatoi I; Shriver CD; Zhu K
Cancer Causes Control; 2012 Jun; 23(6):951-8. PubMed ID: 22527173
[TBL] [Abstract][Full Text] [Related]
33. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
34. Change in health-related quality of life in older women after diagnosis of a small breast cancer.
Euhus DM; Addae JK; Snyder CF; Canner JK
Cancer; 2019 Jun; 125(11):1807-1814. PubMed ID: 30707774
[TBL] [Abstract][Full Text] [Related]
35. Computer-generated nuclear features compared with axillary lymph node status and tumor size as indicators of breast cancer survival.
Wolberg WH; Street WN
Hum Pathol; 2002 Nov; 33(11):1086-91. PubMed ID: 12454812
[TBL] [Abstract][Full Text] [Related]
36. An analysis of immediate postmastectomy breast reconstruction frequency using the surveillance, epidemiology, and end results database.
Agarwal S; Pappas L; Neumayer L; Agarwal J
Breast J; 2011; 17(4):352-8. PubMed ID: 21615823
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.
Elkin EB; Hurria A; Mitra N; Schrag D; Panageas KS
J Clin Oncol; 2006 Jun; 24(18):2757-64. PubMed ID: 16782916
[TBL] [Abstract][Full Text] [Related]
38. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
39. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.
Li CI; Malone KE; Daling JR
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):601-7. PubMed ID: 12101106
[TBL] [Abstract][Full Text] [Related]
40. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups.
Chu KC; Anderson WF; Fritz A; Ries LA; Brawley OW
Cancer; 2001 Jul; 92(1):37-45. PubMed ID: 11443607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
